Intuitive Surgical, Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Intuitive Surgical, Inc. stock analysis ISRG overview
Slightly Bullish +25

QQQ is up 1.3% today, on ISRG stock price movement - Quiver Quantitative

📈 The QQQ ETF rose 1.3% today, driven primarily by an 8.0% surge in Intuitive Surgical (ISRG) stock prices.

💼 ISRG insiders have sold their shares 47 times over the past six months with no recorded purchases.

✅ Wall Street analysts have maintained a positive stance on ISRG, issuing only buy ratings and zero sell ratings recently.

🎯 A group of 15 analysts has provided price targets for ISRG, with a median target price set at $590.0.

📊 These data points regarding insider sales and analyst consensus are sourced from Quiver Quantitative dashboards.

⚠️ Readers are advised that the article contains financial disclaimers regarding potential ticker-mapping errors and lacks formal investment advice.

Bullish Signals
  • Intuitive Surgical (ISRG) stock is up 8.0% today, contributing to the broader QQQ ETF gaining 1.3%.
  • Wall Street sentiment remains strongly bullish with 3 firms issuing buy ratings and zero sell ratings on ISRG in recent months.
  • Analyst price targets indicate significant upside potential, with 15 analysts setting a median target of $590.00.
Risk Factors
  • ISRG insiders have sold shares 47 times over the past six months with zero purchases, indicating significant net selling activity that may signal a lack of internal confidence.
  • While Wall Street analysts currently hold buy ratings, the absence of any sell ratings limits visibility into potential downside risks or conflicting bearish viewpoints from other firms.
Full Analysis
The QQQ ETF rose 1.3% today, driven primarily by an 8.0% gain in Intuitive Surgical Inc. (ISRG) stock prices. This significant move in the ISRG ticker helped bolster broader gains within the technology and healthcare sectors represented in the Nasdaq-100 index. The surge highlights investor confidence in Intuitive Surgical, which is a key component of major market indexes like the QQQ. In terms of insider activity, ISRG has seen substantial net selling over the past six months. Insiders have engaged in open-market transactions 47 times during this period, with all 47 instances being sales and no purchases recorded. While high volume of insider trading can sometimes indicate concern or rebalancing, the consistent lack of buying suggests that internal management is not currently increasing their holdings. Despite the recent insider selling, Wall Street analysts maintain a positive outlook on the stock. Over the last several months, three firms have issued buy ratings for ISRG, with no sell ratings recorded. Additionally, 15 analysts have provided price targets in the past six months, setting a median target price of $590.00. These analyst sentiments suggest that despite insider divestment, external experts view the company's long-term prospects as favorable.